Juno buys cell sequencing firm; set to license tech to CAR-T partner Celgene
T-cell receptor specialist Juno Therapeutics has added a next-generation single cell sequencing platform through the $125m acquisition of AbVitro.
Archives for January 13, 2016
Shire's $32bn Baxalta acq to create largest rare diseases biopharma
Shire has struck a deal to acquire Baxalts but transitioning to a major in-house manufacturer could prove difficult , according to analysts.
GE teams with Canadian Gov to set up C$40m cell therapy tech centre
GE Healthcare has teamed up with the Canadian Government and the Toronto-based Centre for Commercialization of Regenerative Medicine develop cell therapy manufacturing technologies.